Meta Information

ID:cnm-au8

Name:CNM-Au8

Schema Version:1.5

Title

CNM-Au8

Alternate Names

• Gold Nanocrystals
• Gold Nanocatalyst Suspension

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:

0

High Cost:

0

Cost Type:

monthly

Description:

Currently an investigational drug and not commercially available for purchase.

Summary

CNM-Au8 is an oral suspension of gold nanocrystals designed to act as a biocatalyst, improving cellular energy metabolism and resilience. It supports key metabolic cofactors like NAD+ and enhances mitochondrial efficiency, thereby addressing core mechanisms of cellular aging and neurodegeneration. Its primary relevance to healthspan is its potential to restore energetic function and protect cells from age-related decline.

Purpose

Catalyzes cellular energy production to improve mitochondrial function.

Card Summary

An investigational gold nanocrystal suspension designed to boost cellular energy and combat oxidative stress, primarily studied for neurodegenerative diseases.

Drug Class

Drugs In Class

Empty Array

Impact

Score:

3.8

Justification:

Theoretically potent mechanism but lacks direct human evidence for general healthspan or longevity.

Evidence

Grade:

C

Score:

3.5

Justification:

Human trials exist for neurodegenerative disease, but no data for healthspan in healthy individuals.

Safety

Score:

7.5

Justification:

Investigational new drug with no long-term safety data outside of supervised clinical trials.

Flags

• Currently an investigational drug not approved by the FDA for any indication.
• Not available for public purchase; accessible only through clinical trials.
• All human data is in patients with severe neurodegenerative diseases (ALS, MS, Parkinson's).
• Long-term effects of systemic gold nanoparticle exposure in healthy humans are unknown.

Verdict

A promising neuroprotective agent, but highly experimental for any healthspan application.

Created

2026-04-23T23:10:13.081995Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:

oral

Scope:

• systemic

Indication

Focus:

healthspan

Description:

CNM-Au8 is an oral suspension of gold nanocrystals designed to act as a biocatalyst, improving cellular energy metabolism and resilience. It supports key metabolic cofactors like NAD+ and enhances mit...

Typical Protocol

• Clinical trials have investigated oral daily doses ranging from 15mg to 60mg.